After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Guidelines for Adverse Event Reporting of Percutaneous Coronary Intervention (PCI) devices for the Medical Device Manufacturer or its Authorized Representative will be proceeded for endorsement at The GHWP 28th Annual Meeting.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Adverse Event Reporting Guidance for the Medical Device Manufacturer or its Authorized Representative will be proceeded for endorsement at The GHWP 28th Annual Meeting.

Please have the attached Annual Meeting Pragramme (Day 1- Day 4) of GHWP 28th Annual Meeting and 28th GHWP Technical Committee Meeting to be held 9th - 12th December 2024, in Kuala Lumpur of Malaysia.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Amendment 11 to GHWP House Rules will be proceeded for endorsement at The GHWP 28th Annual Meeting.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Amendment 9 to GHWP Terms of Reference and House Rules will be proceeded for endorsement at The GHWP 28th Annual Meeting.

After the receipt of comments from members and the review by the GHWP leadership, the Proposed Final Document: Amendment 10 to GHWP TOR and House Rules on Management Committee will be proceeded for endorsement at The GHWP 28th Annual Meeting.

Updated Sponsorship Package

We are pleased to announce that the updated sponsorship package for the 28th GHWP Annual Meeting & GHWP Technical Committee Meeting are now open. Please refer to the attached document for more information about the sponsorship package. 

Opportunity for Hosting the 29th GHWP Annual Meeting and 29th Technical Committee Meeting in 2025

Live Broadcast Preview

The Opening Ceremony of the 2nd GHWP (Guangzhou) Academy Training

The 2nd GHWP (Guangzhou) Academy Training Notice